Background: Membranous nephropathy (MN) is a specific autoimmune disease affecting kidneys. It is characterized by the accumulation of immune complexes in the glomerular basement membrane. Renal biopsy is currently the standard procedure to confirm the diagnosis, although the presence of autoantibodies against the phospholipase A2 receptor (PLA2R) can also help diagnose. In this study, we aimed to investigate the potential of urinary exosomes as noninvasive markers for diagnosing MN.

Methods: Exosomes were extracted from urine samples of five patients with MN and four healthy controls. The concentration of PLA2R was measured in both urine and isolated exosomes using enzyme-linked immunosorbent assay techniques. The measurements were adjusted based on the urine creatinine (UCr) level of each participant.

Results: The levels of PLA2R/UCr were investigated in urine and urine-derived exosomes from patients and controls. Results of the analysis revealed significantly higher expression of PLA2R/UCr in patients compared to the control group (p < 0.05). Furthermore, the expression level of PLA2R/UCr was higher in urine-derived exosomes than in urine samples. Additionally, a positive correlation was observed between the expression levels of PLA2R/UCr and the urine protein-to-creatinine ratio, with urine-derived exosomes exhibiting a stronger correlation than urine samples.

Conclusion: Studies have indicated that measuring exosomal PLA2R/UCr levels in urine could be a noninvasive method for diagnosing MN. Using urine-derived exosomes could also reduce the burden of performing a biopsy on patients and facilitate follow-up treatment, such as monitoring for future recurrence.

Download full-text PDF

Source
http://dx.doi.org/10.23876/j.krcp.23.208DOI Listing

Publication Analysis

Top Keywords

urine-derived exosomes
16
urine
9
noninvasive method
8
method diagnosing
8
membranous nephropathy
8
exosomes
8
urine samples
8
levels pla2r/ucr
8
pla2r/ucr
5
diagnosing membranous
4

Similar Publications

Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer.

Cancer Lett

January 2025

Division of Immunology and Respiratory Medicine, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden; Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden. Electronic address:

Urinary Bladder Cancer (UBC) ranks among the most prevalent cancers worldwide, has a high recurrence rate and unpredictable treatment responses. Thus, biomarkers are urgently needed. Extracellular vesicles (EVs) are released from both cancer- and immune cells and provide a snapshot of the originating cell.

View Article and Find Full Text PDF
Article Synopsis
  • Understanding the communication between tumor-associated macrophages (TAMs) and tumor cells is essential for improving prostate cancer (PCa) prognosis, with exosomes playing a key role in this process.
  • Research has shown that exosomal PSM-E is upregulated in the exosomes of PCa patients, correlating with more advanced disease stages and promoting tumor suppression by inhibiting M2 polarization of macrophages.
  • The study identifies mechanisms by which exosomal PSM-E interacts with RACK1, influencing signaling pathways to reduce cancer cell proliferation and metastasis.
View Article and Find Full Text PDF

Introduction: Urine-derived exosomes could potentially be biomarkers for bladder cancer (BC) diagnosis. This study aimed to systematically evaluate the diagnostic worth of urine-derived exosomes in BC patients through a meta-analysis of diverse studies.

Methods: A systematic search was carried out in PubMed, Web of Science, Embase, Cochrane, and CNKI databases to obtain the literature concerning the diagnosis of BC via urine-derived exosomes.

View Article and Find Full Text PDF

Exosomes from hypoxic urine-derived stem cells facilitate healing of diabetic wound by targeting SERPINE1 through miR-486-5p.

Biomaterials

March 2025

Department of Orthopedic Surgery and Orthopedic Research Institute, Stem Cell and Tissue Engineering Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, PR China; Frontier Medical Center, Tianfu Jincheng Laboratory, Chengdu, Sichuan, 610212, PR China. Electronic address:

Article Synopsis
  • * The study enhances the angiogenic properties of exosomes from urine-derived stem cells (USCs) by preconditioning them in hypoxia and uses a specially engineered hydrogel, SISMA, to effectively deliver these exosomes at wound sites.
  • * Results show that this hypoxia-treated exosome-loaded hydrogel boosts cell proliferation, migration, and tissue regeneration in injuries, potentially via the activation of HIF-1α signaling and miR-486-5p's role in regulating endothelial cell activity.
View Article and Find Full Text PDF

Preeclampsia is a hypertensive disorder of pregnancy that can lead to stillbirth and preterm birth if not treated promptly. Currently, the diagnosis of preeclampsia relies on clinical symptoms such as hypertension and proteinuria, along with invasive blood tests. Here, we investigate the role of soluble proteins and exosomes in noninvasive diagnosing preeclampsia non-invasively using maternal urine and urine-derived exosomes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!